// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Reproducibility of angle metrics in children using hand‐held spectral domain optical coherence tomography: intra‐observer and inter‐observer variability

B. Edawaji - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes of anterior chamber morphometry with age in children using hand‐held spectral domain optical coherence tomography

B. Edawaji - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cross‐sectional static retinal vessel analysis in routine optometric practice

C. French - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Post‐marketing surveillance study of the safety of dexamethasone intravitreal implant (DEX) in patients with retinal vein occlusion (RVO) or noninfectious posterior segment uveitis (NIPSU)

N.M. Gajate - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Retinal vein occlusion

Dexamethasone

Vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathy with or without preoperative Avastin

C. Garnavou-Xirou - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Microvascular complications of diabetes 1

Bevacizumab

Adaptive optics retinal imaging in patients with GNAT2 mutations

M. Georgiou - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Enzymatic vitreolysis with ocriplasmin for symptomatic vitreomacular traction syndrome

I. Gkizis - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ocriplasmin

Retinal vessel geometry and oxygen saturation in patients suffering from diabetes mellitus and/ or cardiovascular disease

R. Heitmar - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Fluvastatin

Static vessel parameters in health and disease

R. Heitmar - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acquired retinal disease

G. Holder - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An introduction to the tests and clinical interpretation

G. Holder - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of electrophysiology

G. Holder - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Retinal microvascular imaging with adaptive optics

A. Kalitzeos - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Normal upper age‐limits for photopic and mesopic visual acuity and functional contrast sensitivity

A. Keuken - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Anti‐VEGF intravitreal injections in the management of radiation maculopathy ‐ for

M. Sagoo - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interventions to increase attendance for diabetic retinopathy screening: a systematic review and meta‐analysis

J.G. Lawrenson - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

N/A

Refractive Lenticule Transplantation (RLT) for correction of iatrogenic hyperopia and high astigmatism afterLASIK

A. Lazaridis - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Three year results of iStent + phacoemulsification cataract surgery for glaucoma

A. Lewis - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract

N/A

Optimisation of potent topical SRPK1 inhibitors with improved retinal pharmacokinetics through ex vivo trans‐scleral permeability modelling

S. Liddell - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical experience with idebenone in the treatment of patients harboring rare mutations related to Leber's hereditary optic neuropathy (LHON)

X. Llria - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Optic neuropathy

Idebenone

Copyright © 2026. QuantiNova All rights reserved